How big is the Thailand Oral Antidiabetic Drug Market?

The Thailand Oral Antidiabetic Drug Market size is expected to reach USD 82 million in 2024 and grow at a CAGR of greater than 6% to reach USD 109 million by 2029. Read More

What is the current Thailand Oral Antidiabetic Drug Market size?

In 2024, the Thailand Oral Antidiabetic Drug Market size is expected to reach USD 82 million. Read More

Who are the key players in Thailand Oral Antidiabetic Drug Market?

Astrazeneca, Astellas, Janssen, Eli Lilly and Sanofi are the major companies operating in the Thailand Oral Antidiabetic Drug Market. Read More

What years does this Thailand Oral Antidiabetic Drug Market cover, and what was the market size in 2023?

In 2023, the Thailand Oral Antidiabetic Drug Market size was estimated at USD 77.08 million. The report covers the Thailand Oral Antidiabetic Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Thailand Oral Antidiabetic Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Thailand Oral Antidiabetic Drug Companies

This report lists the top Thailand Oral Antidiabetic Drug companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Thailand Oral Antidiabetic Drug industry.